Gujarat Kidney & Super Speciality Ltd
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
- Market Cap ₹ 1,392 Cr.
- Current Price ₹ 177
- High / Low ₹ 181 / 98.2
- Stock P/E 88.0
- Book Value ₹ 32.0
- Dividend Yield 0.00 %
- ROCE 14.5 %
- ROE 11.1 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 172 days.
- Working capital days have increased from 55.7 days to 91.1 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of Nifty IPO BSE Healthcare BSE IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| -0 | 5 | 40 | 82 | 101 | |
| 0 | 3 | 24 | 55 | 74 | |
| Operating Profit | -0 | 2 | 17 | 27 | 27 |
| OPM % | 41% | 41% | 33% | 26% | |
| -0 | 1 | 0 | 1 | 2 | |
| Interest | -0 | 0 | 1 | 2 | 2 |
| Depreciation | -0 | 0 | 3 | 5 | 5 |
| Profit before tax | -0 | 2 | 13 | 21 | 21 |
| Tax % | -0% | 25% | 26% | 21% | |
| -0 | 2 | 10 | 17 | 17 | |
| EPS in Rs | -0.50 | 85.50 | 1.66 | 1.97 | 2.14 |
| Dividend Payout % | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 119% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 1058% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 11 | 16 |
| Reserves | 0 | 11 | 15 | 237 |
| -0 | 6 | 8 | 29 | |
| 4 | 4 | 21 | 16 | |
| Total Liabilities | 4 | 21 | 55 | 298 |
| -0 | 14 | 31 | 129 | |
| CWIP | -0 | -0 | -0 | -0 |
| Investments | -0 | -0 | -0 | -0 |
| 4 | 7 | 24 | 169 | |
| Total Assets | 4 | 21 | 55 | 298 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| -0 | 1 | 14 | -4 | |
| -0 | 0 | -18 | -214 | |
| -0 | -0 | 6 | 228 | |
| Net Cash Flow | -0 | 1 | 2 | 11 |
| Free Cash Flow | -0 | 2 | -5 | -15 |
| CFO/OP | -0% | 70% | 99% | -14% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 321 | 138 | 172 | |
| Inventory Days | 82 | |||
| Days Payable | 339 | |||
| Cash Conversion Cycle | 321 | 138 | -84 | |
| Working Capital Days | 100 | -24 | 91 | |
| ROCE % | 19% | 52% | 14% |
Insights
In beta| Mar 2026 | |
|---|---|
| Acquired Ownership Stake - Ashwini Medical Centre % ・Standalone data |
|
| Acquired Ownership Stake - Harmony Medicare Private Limited % ・Standalone data |
|
| Acquired Ownership Stake - Parekhs Hospital Private Limited % ・Standalone data |
|
| Acquired Ownership Stake - Patel Multispeciality Hospital and ICU % ・Standalone data |
|
| Acquired Ownership Stake - Patel Pharmacy % ・Standalone data |
|
| Acquisition Cost - Ashwini Medical Centre INR ・Standalone data |
|
| Acquisition Cost - Harmony Medicare Private Limited INR ・Standalone data |
|
| Acquisition Cost - Parekhs Hospital Private Limited INR ・Standalone data |
|
| Acquisition Cost - Patel Multispeciality Hospital and ICU INR ・Standalone data |
|
| Acquisition Cost - Patel Pharmacy INR ・Standalone data |
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- AGM To Be Held On 28-09-2026
-
Reg. 34 (1) Annual Report.
- Revised FY2025-26 annual report filed; 7th AGM on 28 September 2026 with multiple shareholder resolutions.
-
Reg. 34 (1) Annual Report.
- 7th AGM on 28 Sep 2026; shareholders to approve director appointments, remuneration revisions and Rs 500 crore borrowing powers.
-
Intimation Of Pre-Advertisement-Notice Of Annual General Meeting Of The Company
- 7th AGM notice published in newspapers; meeting on 28 September 2026 in physical mode.
Business Profile[1]
Gujarat Kidney and Super Speciality Limited is a regional healthcare operator in central Gujarat, running a chain of mid-sized multi-speciality hospitals focused on secondary and tertiary care.